GWM
NVO

GK Wealth Management’s Novo Nordisk NVO Stock Holding History

GK Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,534
Closed -$259K – 145
2025
Q4 		$259K Buy
+6,534
New +$334K 0.17% 141
2025
Q3 		– Sell
-4,816
Closed -$327K – 185
2025
Q2 		$327K Buy
+4,816
New +$328K 0.29% 91

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

GK Wealth Management's NVO Position: Q2 2026 in Review

GK Wealth Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 6,182 shares worth $296K. The stake represents 0.16% of the portfolio and ranks #160 among its holdings. This is a return to the name: GK Wealth Management previously reported a position in NVO as recently as Q3 2025.

GK Wealth Management first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $338K in Q3 2025. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • GK Wealth Management held 6,182 shares of Novo Nordisk worth $296K as of Q2 2026.
  • Novo Nordisk was a new GK Wealth Management position in Q2 2026.
  • Novo Nordisk made up 0.16% of GK Wealth Management's portfolio in Q2 2026, its #160 holding.
  • GK Wealth Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
  • GK Wealth Management's Novo Nordisk position peaked at $338K in Q3 2025.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on GK Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.